Albuterol Sulfate Solution shortage
Resolved 3 presentations · 3 manufacturers · first FDA posting 2022-10-25 · last update 2026-08-27
Manufacturers: Nephron Pharmaceuticals Corporation, Rising Pharma Holdings, Inc., Ritedose Pharmaceuticals, LLC
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Albuterol Sulfate, Solution, 2.5 mg/.5 mL (NDC 0487-9901-30) | Nephron Pharmaceuticals Corporation | Resolved | — | Available | Posted 10/25/2022 Updated 08/27/2026 |
| Albuterol Sulfate, Solution, 2.5 mg/.5 mL (NDC 64980-642-03) | Rising Pharma Holdings, Inc. | Resolved | — | Available | Posted 10/25/2022 Updated 08/27/2026 |
| Albuterol Sulfate, Solution, 2.5 mg/.5 mL (NDC 76204-027-01) | Ritedose Pharmaceuticals, LLC | Resolved | — | Available | Posted 10/25/2022 Updated 08/27/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)